Deoxymikanolide adversely altered physiology and ultrastructure of Ralstonia solanacearum

Pestic Biochem Physiol. 2021 May:174:104803. doi: 10.1016/j.pestbp.2021.104803. Epub 2021 Feb 24.

Abstract

Deoxymikanolide (DEO) was isolated from Mikania micrantha Bunge and identified as a novel antibacterial compound previously. However, the mode of antimicrobial mechanism of DEO was not clear but hypothesized to affect the morphology and physiology of Ralstonia solanacearum cells. In this study, we confirmed our hypothesis via transmission electron microscopy (TEM) observation and comprehensive physiological analyses, including electric conductivity, glycan and phosphorus metabolism, activities of antioxidant enzymes (catalase, peroxidase, and superoxide dismutase), intrabacterial reactive oxygen species (ROS), and malondialdehyde (MDA) levels. We found that glycan and phosphorus metabolism, electric conductivity, intracellular ROS and MDA levels of R. solanacearum cells were significantly increased, while the activities of three antioxidant enzymes were significantly inhibited by DEO treatment. Moreover, TEM analysis showed that DEO treatment led to an early-stage of cell shrinkage, intermediate-stages of cytoplasmic damage, and a final-stage of cell disruption. Altogether, our data presented here indicate that DEO could adversely affect the physiology and morphology of R. solanacearum cells and be treated as an alternative antibacterial treatment in the future.

Keywords: Electric conductivity; Energy metabolism; Intrabacterial ROS and MDA levels; Mikania micrantha Bunge; Ultrastructural changes.

MeSH terms

  • Catalase
  • Lactones
  • Ralstonia solanacearum*
  • Sesquiterpenes, Germacrane

Substances

  • Lactones
  • Sesquiterpenes, Germacrane
  • deoxymikanolide
  • Catalase